International Cross-Sectional Survey on Management of Type II Endoleak and the Role of Preemptive Embolization
Annals of Vascular Surgery · 2025
DOI: 10.1016/j.avsg.2025.02.027 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Annals of Vascular Surgery, 2025. Verfasst von Mohammed Habib und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Surgery, Umm Al-Qura University, Makkah, Saudi Arabia. Hauptthemen laut MEDLINE: Endoleak, Endovascular Procedures, Embolization, Therapeutic, Blood Vessel Prosthesis Implantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Type II endoleaks (TIIELs) commonly occur following endovascular aneurysm repair (EVAR). There is a lack of unified consensus regarding the management of TIIEL. Preemptive embolization is a potential method to reduce the risk for TIIEL, but its role is debated. We performed a survey among aortic experts internationally to assess perspectives on TIIEL management and the role of preemptive embolization. METHODS: A questionnaire was prepared covering aspects on effect of TIIEL on EVAR outcome, strategies to manage TIIEL, and attitudes toward preemptive embolization techniques. The questionnaire was distributed using an online platform among vascular specialists across 80 specialized aortic centers worldwide. RESULTS: Of 80 survey recipients, 56 (70%) responded. Only 12% of participants did not believe TIIEL to affect the durability of EVAR. Nearly 82.2% of respondents believed TIIEL increases the likelihood of reintervention. One-quarter agreed that TIIEL increases aortic-related mortality post-EVAR. For established TIIEL, 12% find "any sac expansion" to be an indication for intervention, while 41% would intervene at >5 mm sac expansion, and 52% at >10 mm sac expansion. Majority (63%) perform selective embolization in this setting. Only 3.6% of participants reported routinely conducting preemptive embolization in over 30% of their EVAR cases, while 42.9% never performed this procedure, and 53.6% performed preemptive embolization in
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Faculty of Medicine, Department of Surgery, Umm Al-Qura University, Makkah, Saudi Arabia.
- Division of Vascular and Endovascular Surgery, Department of Clinical Surgical and Health Sciences, University of Trieste, Trieste, Italy.
- Division of Vascular Surgery, Department of Cardiothoracic- and Vascular Surgery, Aarhus University Hospital, Aarhus, Denmark.
- Section of Vascular Surgery, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden. Electronic address: kevin.mani@uu.se.
Zitieren
APA
Habib, M., D'Oria, M., Budtz-Lilly, J., & Mani, K. (2025). International Cross-Sectional Survey on Management of Type II Endoleak and the Role of Preemptive Embolization. Annals of Vascular Surgery. https://doi.org/10.1016/j.avsg.2025.02.027
Vancouver
Habib M, D'Oria M, Budtz-Lilly J, Mani K. International Cross-Sectional Survey on Management of Type II Endoleak and the Role of Preemptive Embolization. Annals of Vascular Surgery. 2025. doi:10.1016/j.avsg.2025.02.027
BibTeX
@article{Habib2025,
author = {Habib, Mohammed and D'Oria, Mario and Budtz-Lilly, Jacob and Mani, Kevin},
title = {International Cross-Sectional Survey on Management of Type II Endoleak and the Role of Preemptive Embolization},
journal = {Annals of Vascular Surgery},
year = {2025},
doi = {10.1016/j.avsg.2025.02.027}
}
EUVIMED